KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Non-Current Debt (2022 - 2025)

Historic Non-Current Debt for Adaptive Biotechnologies (ADPT) over the last 4 years, with Q3 2025 value amounting to $129.4 million.

  • Adaptive Biotechnologies' Non-Current Debt fell 248.0% to $129.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $129.4 million, marking a year-over-year decrease of 248.0%. This contributed to the annual value of $132.4 million for FY2024, which is 134.24% up from last year.
  • Per Adaptive Biotechnologies' latest filing, its Non-Current Debt stood at $129.4 million for Q3 2025, which was down 248.0% from $130.5 million recorded in Q2 2025.
  • Adaptive Biotechnologies' Non-Current Debt's 5-year high stood at $132.7 million during Q3 2024, with a 5-year trough of $125.4 million in Q4 2022.
  • For the 4-year period, Adaptive Biotechnologies' Non-Current Debt averaged around $130.3 million, with its median value being $131.1 million (2023).
  • As far as peak fluctuations go, Adaptive Biotechnologies' Non-Current Debt skyrocketed by 471.16% in 2024, and later plummeted by 248.0% in 2025.
  • Quarter analysis of 4 years shows Adaptive Biotechnologies' Non-Current Debt stood at $125.4 million in 2022, then rose by 4.23% to $130.7 million in 2023, then increased by 1.34% to $132.4 million in 2024, then fell by 2.27% to $129.4 million in 2025.
  • Its Non-Current Debt stands at $129.4 million for Q3 2025, versus $130.5 million for Q2 2025 and $131.5 million for Q1 2025.